Joys of Compounding

Jeff Marrazzo - Compounding for a Cure - [Art of Investing, EP.7]

Nov 27, 2023
Jeff Marrazzo, Co-Founder and former CEO of Spark Therapeutics, discusses the revolutionary breakthrough in gene therapy for inherited retinal disease. He shares the story of Spark Therapeutics, the first company to develop an FDA-approved gene therapy. They also explore the impact of locating a company and research commercialization, merging sectors for making an impact, and the future of life sciences and healthcare.
Ask episode
Chapters
Transcript
Episode notes